Dear Friends and Colleagues,

GLP-1 agonists are modernizing medicine—redefining care in diabetes, obesity, MASH, the cardiometabolic syndrome and PCOS. Recent evidence suggests that these powerful therapies may also affect management of chronic inflammatory immune mediated diseases (Dermatology, GI, Rheumatology and others), particularly through their impact on systemic inflammation and metabolic dysfunction. As clinicians, we are increasingly confronted with such patients whose inflammatory skin conditions are closely intertwined with obesity and the metabolic syndrome—yet a dedicated forum addressing this critical multi-organ interplay has been missing.

To meet this need, we are delighted to invite you to a high-impact, one-day scientific meeting focused exclusively on this evolving field of the Metabolic Syndrome and GLP-1s.

         Event Date: Wednesday, July 15, 2026

Location: The New York Academy of Medicine, New York City
                     1216 Fifth Avenue (at 103rd Street) New York, NY 10029

This will be a CME-certified event organized by the team behind the biennial Inflammatory Skin Disease Summit, in partnership with the IDEF. This meeting will bring together world leaders on skin inflammation and longevity, GI, MASH, the cardiometabolic syndrome and GLP-1 mechanisms, to deliver cutting-edge science, clinical insights, and practical takeaways that you can apply immediately to patient care.

We look forward to welcoming you to New York,
ISDS Organizing Committee

In collaboration with

Leon H. Kircik, MD

International Dermatology Education Foundation